Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report.

IF 1 4区医学 Q3 MEDICINE, GENERAL & INTERNAL World Journal of Clinical Cases Pub Date : 2024-10-06 DOI:10.12998/wjcc.v12.i28.6217

Rahaf Jalal Altwijri, Ehab Alsirhy

{"title":"Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report.","authors":"Rahaf Jalal Altwijri, Ehab Alsirhy","doi":"10.12998/wjcc.v12.i28.6217","DOIUrl":null,"url":null,"abstract":"Background: Glaucoma is caused by increased intraocular pressure (IOP) that damages the optic nerve, leading to blindness. The Ahmed glaucoma valve (AGV) is a glaucoma drainage implant device that is used in glaucoma patients with uncontrolled IOP. A possible complication after any ocular surgery however is hyphema, which can itself progress to uveitis glaucoma hyphema (UGH) syndrome on rare occasions. UGH syndrome has not yet been reported as a complication of AGV implantation.Case summary: Here, we have reported a case of a 55-year-old female who developed both hyphema and pigmentation as a result of AGV implantation. We confirmed UGH syndrome secondary to AGV implantation after the patient underwent another surgery to shorten and reposition the AGV tube. After the second surgery, the patient's IOP was reduced, and she had a clear cornea and no signs of hyphema.Conclusion: This first report of UGH syndrome as a complication of AGV implantation reminds clinicians that frequent follow-up is paramount.","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362883/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Clinical Cases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12998/wjcc.v12.i28.6217","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Glaucoma is caused by increased intraocular pressure (IOP) that damages the optic nerve, leading to blindness. The Ahmed glaucoma valve (AGV) is a glaucoma drainage implant device that is used in glaucoma patients with uncontrolled IOP. A possible complication after any ocular surgery however is hyphema, which can itself progress to uveitis glaucoma hyphema (UGH) syndrome on rare occasions. UGH syndrome has not yet been reported as a complication of AGV implantation.

Case summary: Here, we have reported a case of a 55-year-old female who developed both hyphema and pigmentation as a result of AGV implantation. We confirmed UGH syndrome secondary to AGV implantation after the patient underwent another surgery to shorten and reposition the AGV tube. After the second surgery, the patient's IOP was reduced, and she had a clear cornea and no signs of hyphema.

Conclusion: This first report of UGH syndrome as a complication of AGV implantation reminds clinicians that frequent follow-up is paramount.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

青光眼植入物导致的葡萄膜炎青光眼低红斑综合征：病例报告。

背景：青光眼是由眼压升高引起的，眼压升高会损害视神经，导致失明。艾哈迈德青光眼瓣膜（AGV）是一种青光眼引流植入装置，用于眼压无法控制的青光眼患者。然而，任何眼科手术后可能出现的并发症都是眼底出血，在极少数情况下，眼底出血会发展成葡萄膜炎青光眼眼底出血综合征（UGH）。病例摘要：我们在此报告了一例 55 岁女性的病例，她在植入 AGV 后出现了红斑和色素沉着。在患者接受了另一次缩短 AGV 管并重新定位的手术后，我们确认了继发于 AGV 植入的 UGH 综合征。第二次手术后，患者的眼压降低了，角膜清晰，也没有红斑症状：结论：这是首例关于 AGV 植入并发症 UGH 综合征的报告，提醒临床医生必须经常进行随访。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

World Journal of Clinical Cases Medicine-General Medicine

自引率

0.00%

发文量

3384

期刊介绍： The World Journal of Clinical Cases (WJCC) is a high-quality, peer reviewed, open-access journal. The primary task of WJCC is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of clinical cases. In order to promote productive academic communication, the peer review process for the WJCC is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCC are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in clinical cases.